S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

实时更新: enVVeno Medical [NVNO]

交易所: NASDAQ 部门: Healthcare 工业: Medical Devices
Upcoming Earnings Alert

Quarter results tomorrow
(bmo 2024-05-06)

Expected move: +/- 8.91%

最后更新时间4 May 2024 @ 04:00

-0.20% $ 5.05

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases...

Stats
今日成交量 21 804.00
平均成交量 130 001
市值 67.25M
EPS $0 ( 2024-02-29 )
下一个收益日期 ( $-0.400 ) 2024-05-06
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.64
ATR14 $0.0300 (0.59%)
Insider Trading
Date Person Action Amount type
2024-03-13 Alavi Hamed Sell 8 334 Stock Options
2024-03-13 Alavi Hamed Buy 8 334 Common Stock
2024-03-13 Alavi Hamed Sell 8 334 Common Stock
2023-12-05 Glynn Craig Buy 75 000 Stock Options
2023-12-05 Jenusaitis Matthew Buy 13 856 Stock Options
INSIDER POWER
44.24
Last 98 transactions
Buy: 6 344 915 | Sell: 2 475 147

音量 相关性

長: -0.12 (neutral)
短: 0.18 (neutral)
Signal:(44.937) Neutral

enVVeno Medical 相关性

10 最正相关
LRMR0.878
CFLT0.862
TYRA0.859
POWL0.858
MPWR0.844
SGMO0.827
VEON0.825
LBC0.823
FWRG0.82
REYN0.817
10 最负相关
GRNA-0.858
SGLY-0.849
GIPR-0.84
SGLB-0.814
GROW-0.811
ITRM-0.803
DCRC-0.801

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

enVVeno Medical 相关性 - 货币/商品

The country flag 0.24
( neutral )
The country flag 0.35
( neutral )
The country flag 0.00
( neutral )
The country flag 0.36
( neutral )
The country flag -0.64
( weak negative )
The country flag -0.66
( moderate negative )

enVVeno Medical 财务报表

Annual 2023
营收: $0
毛利润: $-546 000 (0.00 %)
EPS: $-1.910
FY 2023
营收: $0
毛利润: $-546 000 (0.00 %)
EPS: $-1.910
FY 2022
营收: $0
毛利润: $-525 000 (0.00 %)
EPS: $-2.16
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-12.80

Financial Reports:

No articles found.

enVVeno Medical

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。